CSIMarket


Candel Therapeutics Inc   (CADL)
Other Ticker:  
 
 

CADL's Operating Income Growth by Quarter and Year

Candel Therapeutics Inc 's Operating Income results by quarter and year




CADL Operating Income (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 0.00 0.00 0.00
III Quarter September -8.03 0.00 0.00 0.00
II Quarter June -5.30 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -13.33 - - -



CADL Operating Income third quarter 2021 Y/Y Growth Comment
Candel Therapeutics Inc in the third quarter recorded Operating Loss of $ -8.03 millions.

According to the results reported in the third quarter, Candel Therapeutics Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Candel Therapeutics Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter.

Explain Operating Income growth


CADL Operating Income ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Candel Therapeutics Inc 's third quarter 2021 Operating Income $ -8.03 millions CADL's Income Statement
Candel Therapeutics Inc 's third quarter 2020 Operating Income $ 0.00 millions Quarterly CADL's Income Statement
New: More CADL's historic Operating Income Growth >>


CADL Operating Income (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Candel Therapeutics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CADL's III. Quarter Q/Q Operating Income Comment
Current Operating Loss of -8.03 millions by Candel Therapeutics Inc appear even worse considering the Operating Loss -5.30 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Candel Therapeutics Inc achieved highest sequential Operating Income growth. While Candel Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CADL's III. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -8.03 millions by Candel Therapeutics Inc come out even more unfavourable if you take a look at -5.30 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Candel Therapeutics Inc achieved highest sequential Operating Income growth. While Candel Therapeutics Inc 's Operating Income growth quarter on quarter, overall rank is .


Candel Therapeutics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Operating Income 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
In the Sep 30 2021 period, Candel Therapeutics Inc 's cumulative trailing twelve month Operating Income remained unchanged compare to the same period a year ago.

Candel Therapeutics Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CADL's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CADL's Competitors
Operating Income Growth for Candel Therapeutics Inc 's Suppliers
Operating Income Growth for CADL's Customers

You may also want to know
CADL's Annual Growth Rates CADL's Profitability Ratios CADL's Asset Turnover Ratio CADL's Dividend Growth
CADL's Roe CADL's Valuation Ratios CADL's Financial Strength Ratios CADL's Dividend Payout Ratio
CADL's Roa CADL's Inventory Turnover Ratio CADL's Growth Rates CADL's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2021 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2021
Regional Health Properties Inc -0.32%$ -0.317 millions
Abiomed Inc -1.47%$ -1.467 millions
Integra Lifesciences Holdings Corp-1.92%$ -1.917 millions
Semler Scientific inc -5.44%$ -5.437 millions
Phibro Animal Health Corp-6.86%$ -6.859 millions
Quidel Corporation-8.48%$ -8.481 millions
Conmed Corporation-9.09%$ -9.091 millions
Quest Diagnostics Inc-9.19%$ -9.192 millions
Lemaitre Vascular Inc-9.43%$ -9.433 millions
Universal Health Services Inc -9.97%$ -9.970 millions
Amedisys Inc-10.33%$ -10.331 millions
Meridian Bioscience Inc -10.40%$ -10.397 millions
Fourth Wave Energy Inc -10.53%$ -10.525 millions
Fitlife Brands Inc -13.80%$ -13.795 millions
Fonar Corporation-13.94%$ -13.941 millions
Essa Pharma inc -14.07%$ -14.072 millions
Pro dex Inc -14.91%$ -14.913 millions
U S Physical Therapy Inc-15.06%$ -15.064 millions
Owens and Minor Inc -16.78%$ -16.780 millions
Protokinetix Incorporated-16.92%$ -16.917 millions
Steris Plc-17.53%$ -17.528 millions
Electromed Inc -18.85%$ -18.852 millions
Biodelivery Sciences International Inc -20.22%$ -20.222 millions
Alr Technologies Inc -21.93%$ -21.929 millions
Petmed Express Inc-22.77%$ -22.768 millions
Retractable Technologies inc -23.02%$ -23.019 millions
Vyne Therapeutics Inc -24.33%$ -24.328 millions
Laboratory Corporation Of America Holdings-26.76%$ -26.760 millions
Biogen Inc -26.91%$ -26.915 millions
Viemed Healthcare Inc -27.75%$ -27.748 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

INKT's Profile

Stock Price

INKT's Financials

Business Description

Fundamentals

Charts & Quotes

INKT's News

Suppliers

INKT's Competitors

Customers & Markets

Economic Indicators

INKT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071